SNHN Education Events

« All Events

  • This event has passed.

Better musculoskeletal health: identifying effective care for low back pain and osteoarthritis

Wed 8th December 2021 @ 6:30 pm

Over 6 million Australians in the world suffer from debilitating musculoskeletal pain, most commonly low back pain (LBP) and osteoarthritis (OA). These pervasive conditions limit people’s capacity to function normally and cost over $8 billion/year in healthcare with an additional $11billion in lost work productivity. In Australia, management of OA and LBP tends to occur mostly in primary care settings, resulting in a significant burden to our health care system. Moreover, despite their significant burden, patients with these conditions are commonly offered treatments that do not work (e.g. simple analgesics, corticosteroids, anti-inflammatories, opioids), but have limited access to treatments that do work (e.g. self-management; physical and psychological treatments). When patients fail to improve, they tend to seek more complex treatments, such as surgery, which is an expensive and high-risk approach that remains of questionable efficacy in addressing these conditions.

Format of webinars:
Two 90-minute webinars will be offered on recommended care for LBP, knee, hip or hand OA. The first webinar will discuss the burden and management of LBP, whilst the second webinar will introduce evidence-based management options for OA.

 

Webinar 2: Better musculoskeletal health: identifying effective care for osteoarthritis

Wednesday 8th December, 6:30 – 8:30pm
Topics:

  1. What is osteoarthritis (mechanisms and pathophysiology)?
  2. What is the burden of knee, hip and hand OA?
  3. What are the personal impacts of OA?
  4. How to diagnose OA & when is imaging needed?
  5. What is the typical management of OA (and where are we failing?)?
  6. What is the current best-evidence management for OA (pharmacological & non-pharmacological)?
  7. Why is taking a biopsychosocial approach for OA important?
  8. What are the risk factors for and how can we prevent OA?
  9. What is an acute exacerbation (flare up) of OA?
  10. What is the evidence-based management for acute exacerbations of OA?
  11. What are the treatments that should be avoided for acute exacerbations of OA?
  12. What is the current evidence for surgical treatments for OA?

REGISTER HERE

DATE:
Wed 8th December 2021


TIME:
6:30 pm - 8:30 pm


SPEAKERS:

Professor Ferreira
Professor Ferreira is Principal Research Fellow and NHMRC Research Fellow. She leads the clinical back pain research theme at The Kolling Institute, where she oversees a research team on the mechanisms, prognosis and management of back pain. Her research has changed the way LBP is managed by providing much-needed evidence that the most common pain medications for LBP offer little or no benefit and shifting the focus to exercise and self-management. This work informed 30+ clinical practice guidelines in 19 countries, many of which have since removed pharmacological management as first line care. Her research has also shaped drug deprescribing guides for non-cancer pain in Australia and informed 16+ international (e.g. Canada, UK, USA, France, Denmark, Russia) clinical decision-support tools and training resources on better use of analgesics for LBP and OA. She currently leads multiple randomised controlled trials of back pain interventions, including the first placebo randomised controlled trial of spinal surgery, an NHMRC-funded study that will establish the efficacy of decompressive surgery for lumbar spinal stenosis.

Dr Jillian Eyles
Dr Jillian Eyles is a physiotherapist and early career researcher at with the Osteoarthritis (OA) Clinical Research Group, Institute of Bone and Joint Research, The University of Sydney, situated in the Kolling Institute of Medical Research. Dr Eyles’ main areas of interest lie in clinical and implementation research relating to non-surgical management of OA. Her recent work has focused on the implementation and outcomes of OA management programs that deliver recommended first-line management to people living with symptomatic OA. Her vision is to ensure people with OA receive the best possible high-value care by:
i) establishing which methods of care delivery offer them the best results, and are most cost-effective,
ii) developing tools to support healthcare practitioners to deliver high-value OA care.
Dr Eyles has 42 publications in international peer-reviewed journals and has been awarded >$2.5 million for her projects by the Australian government and industry partners.

The osteoarthritis seminar will feature a 40-minute presentation followed by a 50-minute Q & A session with an expert panel:
1. Prof David Hunter- Florance & Cope Chair of Rheumatology and consultant Rheumatologist
2. Carin Pratt- Senior Physiotherapist and Musculoskeletal Coordinator for the Osteoarthritis Chronic Care Program, Royal North Shore Hospital
3. Rosie Venman- Dietitian, Osteoarthritis Chronic Care Program, Royal North Shore Hospital.

TARGET AUDIENCE:

GPs, Practice Nurses, Pharmacists and Allied Health Professionals.



ENQUIRIES:

Judy or Robi, Education Coordinators – 9432 8250 or events@snhn.org.au.





REGISTRATION IS MANDATORY FOR ATTENDANCE.
+ iCALENDAR EXPORT  + GOOGLE CALENDAR EXPORT
^ We will use this email as your preferred email for event communication purposes (e.g. registrations, associated materials, certificates). We will also use it for future SNHN communications unless you request otherwise.

To view our Event Invoicing, Payments and Refunds Policy please click here.